-
公开(公告)号:US20190231902A1
公开(公告)日:2019-08-01
申请号:US16312277
申请日:2017-06-21
申请人: University of Florida Research Foundation, Incorporated , Board of Supervisors of Louisiana State University & Agricultural & Mechanical College
发明人: David C. Bloom , Alfred S. Lewin , Donna M. Neumann , Zachary L. Watson , Sonal Sanjeev Tuli , Gregory Scott Schultz
IPC分类号: A61K48/00 , C12N5/0793 , C12N15/86 , C12N15/113 , A61P31/22
CPC分类号: A61K48/0091 , A61P31/22 , C12N5/062 , C12N15/1133 , C12N15/86 , C12N2310/121 , C12N2310/20 , C12N2320/32 , C12N2510/00 , C12N2750/14122 , C12N2750/14143 , C12N2750/14145
摘要: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
-
公开(公告)号:US20220380808A1
公开(公告)日:2022-12-01
申请号:US17738987
申请日:2022-05-06
申请人: University of Florida Research Foundation, Incorporated , Board of Supervisors of Louisiana State University & Agricultural & Mechanical College
发明人: David C. Bloom , Alfred S. Lewin , Donna M. Newmann , Zachary L. Watson , Sonal Sanjeev Tuli , Gregory Scott Schultz
IPC分类号: C12N15/861 , A61P31/22
摘要: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
-
公开(公告)号:US11351273B2
公开(公告)日:2022-06-07
申请号:US16312277
申请日:2017-06-21
申请人: University of Florida Research Foundation, Incorporated , Board of Supervisors Of Louisiana State University & Agricultural & Mechanical College
发明人: David C. Bloom , Alfred S. Lewin , Donna M. Neumann , Zachary L. Watson , Sonal Sanjeev Tuli , Gregory Scott Schultz
IPC分类号: C07H21/04 , A61K48/00 , C12N15/113 , C12N15/86 , A61P31/22 , C12N5/0793
摘要: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
-
-